From HuGE Literature Finder Database
This database contains published literature on genetic associations and other human genome epidemiology
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Journal of the National Cancer Institute 2017 Jul 109 (7): .
Kuchenbaecker Karoline B, McGuffog Lesley, Barrowdale Daniel, Lee Andrew, Soucy Penny, Dennis Joe, Domchek Susan M, Robson Mark, Spurdle Amanda B, Ramus Susan J, Mavaddat Nasim, Terry Mary Beth, Neuhausen Susan L, Schmutzler Rita Katharina, Simard Jacques, Pharoah Paul D P, Offit Kenneth, Couch Fergus J, Chenevix-Trench Georgia, Easton Douglas F, Antoniou Antonis - A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 May 28 (5): 996-1004.
Monk B J, Brady M F, Aghajanian C, Lankes H A, Rizack T, Leach J, Fowler J M, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher E M, Anderson K S, Gottardo R, Bryan J K, Newkirk M, Manjarrez K L, Mannel R S, Hershberg R M, Coukos - Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA oncology 2017 Apr .
Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill - Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer.
Gynecologic oncology 2017 Apr .
Bookman Michael A, Tyczynski Jerzy E, Espirito Janet L, Wilson Thomas W, Fernandes Ancilla - INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer.
Gene therapy 2017 Apr .
Hu J-L, Hu X-L, Han Q, Guo A-Y, Wang C-J, Wen Y-Y, Cang S
No hay comentarios:
Publicar un comentario